Phase 3 Biomarker Clinical Trials

2 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–2 of 2 trials

Recruiting

Phase 3

LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome

EpilepsyAlzheimer DiseaseSeizures+7 more

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau120 enrolled5 locationsNCT07234695

Recruiting

Phase 2Phase 3

Dapaglifozin to Avoid Acute Kindey Injury (AKI) to Chronic Kidney Disease (CKD) Transition: DAKI-CKD Study

BiomarkersAKI - Acute Kidney InjuryCKD+1 more

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran100 enrolled1 locationNCT05713851